Shimadaya Corporation
250A・Standard Market・Foods
Business
Shimadaya Corporation is a noodle-specialty manufacturer founded in 1931, forming a five-company group that includes four consolidated subsidiaries: Shimadaya Kanto, Shimadaya Tohoku, Shimadaya Nishi Nihon, and Shimadaya Shoji. In its household-use business segment, the company manufactures and sells chilled noodles, frozen noodles, and long-life noodles to mass retailers such as supermarkets, while in its commercial-use business segment it manufactures and sells frozen noodles to restaurants and prepared-food retailers. The company operates 11 plants (8 for chilled noodles, 3 for frozen noodles) mainly across Honshu, and newly listed on the Tokyo Stock Exchange Standard Market in October 2024. Net sales for FY2026 (ending March 2026) were ¥41,061 million.
Business Model
Raw material procurement is centralized through parent company Shimadaya, which acts as the sole purchasing channel and supplies materials to manufacturing subsidiaries on a fee basis, concentrating cost control. Sales are handled by the parent company: household-use products are sold to mass retailers, while commercial-use products are marketed through proposal-based sales to wholesalers, trading companies, and major foodservice chains. The company secures added value through high-quality production at FSSC22000-certified plants and proprietary brands such as "Ryusui-men" and "Kenbi-men", maintaining a profit structure that absorbs cost increases through price revisions.
Company Strengths
The FY2025 nationwide sales value share of chilled noodles for household use was 10.8% (No. 2 position), and 20.6% (No. 2 position) in the Kanto area (per Intage SCI survey). In frozen noodles for commercial use, the company also held a No. 2 nationwide share of 19.0% (per TPC Marketing Research survey). As a noodle-specialist manufacturer, the company maintains high shares in both the household and commercial-use segments, with brand recognition and the depth of its sales network forming the basis of its competitive advantage.
FSSC22000 (an international food safety management standard) has been obtained at all production sites, including 8 plants for household chilled noodles, 3 plants for frozen noodles, and 4 plants for commercial-use frozen noodles. By maintaining international food safety certification across all plants, the company ensures stable supply and quality reliability to mass retailers and restaurant chains, forming a barrier to entry against regional and local noodle manufacturers.
The company holds a group of differentiated products backed by proprietary technologies, including "Ryusuimen" (Ryusuimen, a proprietary technology allowing noodles to be loosened simply with water), launched in 1988, the health-oriented "Kenbimen", "LL noodles" with a 100-day room-temperature shelf life, and the commercial-use "Ryusui Alpha Men" (which maintains texture even after time has passed). The company has established a product development framework based on the development keyword "7K" (health, convenience, high quality, stockpiling, economy, domestic production, and environment), investing ¥485 million in research and development expenses (FY2026, ending March 2026).
ENVALITH's Perspective
Performance Trend
FY2025 (ended March 2025): Net sales ¥39,625 million, operating profit ¥3,372 million → FY2026 (ending March 2026): Net sales ¥41,061 million (up 3.6%), operating profit ¥3,768 million (up 11.7%), ordinary profit ¥3,874 million (up 12.3%), profit attributable to owners of parent ¥2,596 million (up 1.6%). Price revision effects and cost containment absorbed increases in logistics costs and manufacturing labor costs, improving the operating profit margin from 8.5% to 9.2%. As an external factor, the spread of food price revisions and the recovery in dining-out demand boosted commercial-use sales. Meanwhile, the recognition of an impairment loss of ¥211 million restrained growth in net profit. The company's forecast for FY2027 (ending March 2027) is net sales of ¥43,400 million (up 5.7%) and operating profit of ¥3,700 million (down 1.8%), indicating a revenue increase alongside a decline in operating profit.
Growth Strategy
Final year of "Change95": Sustainable growth through deepening core businesses, expanding new business areas, and promoting DX
Promoting expansion of the "Kenbimen" (health-oriented) and "Taikoban" (value-oriented) brands and growing share in the western Japan area. In FY2026 (ending March 2026), "Kenbimen" meal volume exceeded the prior year. FY2027 (ending March 2027) positions improvement of household chilled business profitability as a key initiative in the final year of the medium-term plan.
Aiming to expand sales of commercial-use frozen noodles centered on the "Taikoban" brand, leveraging growing demand from the eating-out sector. Commercial-use sales in FY2026 (ending March 2026) increased 5.9% year on year. The company continues to target profitability improvement in FY2027 (ending March 2027) as well.
Overseas sales are positioned as a growth area and continued to increase steadily in FY2026 (ending March 2026). Household-use frozen noodles are also being pursued as a new business area for sales expansion. Continued investment is being made as a pillar of the profit structure transformation under the medium-term plan.
Proceeding with production system restructuring, including the closure of the Shimadaya Tohoku Sendai Plant (FY2026, ending March 2026), while implementing capital expenditures with tangible fixed asset acquisitions of ¥2,852 million (a significant increase from ¥1,444 million in the previous fiscal year). Also working to improve productivity through DX promotion.
The policy is stable dividends based on a target consolidated payout ratio of 30–40%. FY2026 (ending March 2026) annual dividend was ¥52 (payout ratio 30.4%), and the FY2027 (ending March 2027) forecast is an annual dividend of ¥54 (payout ratio 29.7%). Share buybacks (¥1,422 million) were also conducted, expanding the total return amount.
Last updated: July 19, 2026